IMC Chicago’s ETRACS 2x Leveraged US Growth Factor TR ETN IWFL Stock Holding History

IMC Chicago’s Portfolio IWFL Stock Details IWFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,157	Closed	-$533K	–	3734
2025 Q2	$533K	Buy	+11,157	New	+$444K	﹤0.01%	2824
2023 Q3	–	Sell	-11,543	Closed	-$295K	–	1615
2023 Q2	$295K	Buy	11,543 +4	+0%	+$89	﹤0.01%	1247
2023 Q1	$239K	Buy	+11,539	New	+$214K	﹤0.01%	1258
2022 Q1	–	Sell	-13,614	Closed	-$497K	–	1153
2021 Q4	$497K	Sell	13,614 -7,292	-35%	-$252K	﹤0.01%	1100
2021 Q3	$620K	Buy	20,906 +6,956	+50%	+$220K	﹤0.01%	1077
2021 Q2	$408K	Buy	+13,950	New	+$369K	﹤0.01%	1030

IMC Chicago's IWFL Position: Q3 2025 in Review

IMC Chicago sold out of ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) in Q3 2025, closing a stake of 11,157 shares — an estimated $533K sold.

IMC Chicago first reported a position in IWFL in Q2 2021 and held it in 6 quarters. The position peaked at $620K in Q3 2021. 0 funds tracked by Wall St. Rank hold IWFL as of Q3 2025.

IMC Chicago reported no remaining ETRACS 2x Leveraged US Growth Factor TR ETN position as of Q3 2025 after selling out during the quarter.
IMC Chicago sold 11,157 ETRACS 2x Leveraged US Growth Factor TR ETN shares in Q3 2025, an estimated $533K.
IMC Chicago first reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN in Q2 2021 and held it in 6 quarters.
IMC Chicago's ETRACS 2x Leveraged US Growth Factor TR ETN position peaked at $620K in Q3 2021.
0 funds tracked by Wall St. Rank held ETRACS 2x Leveraged US Growth Factor TR ETN as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.